Fund HoldingsSands Capital Alternatives, LLC

Total Portfolio Value
$613.55M
Total Bought
$171.30M
Total Sold
$11.96M
Net Transaction
+$159.34M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
ALAMAR BIOSCIENCES INC04,230,926+4,230,9260114,61618.68%+114,616
BETA BIONICS INC(BBNX)3,708,0433,708,043037,15558,1059.47%+20,950
ODYSSEY THERAPEUTICS INC0875,000+875,000016,3712.67%+16,371
DATADOG INC(DDOG)85,79380,851-4,94210,12821,0503.43%+10,923
10X GENOMICS INC(TXG)481,770481,770010,22818,4713.01%+8,243
CEREBRAS SYSTEMS INC032,825+32,82507,2541.18%+7,254
DOORDASH INC(DASH)111,231127,562+16,33116,70123,5393.84%+6,838
BIOAGE LABS INC(BIOA)786,353786,353013,75319,2743.14%+5,520
INHIBIKASE THERAPEUTICS INC(IKT)13,018,96513,018,965021,87226,4284.31%+4,557
COUPANG INC(CPNG)1,012,0911,329,314+317,22319,10823,0903.76%+3,982
SNOWFLAKE INC(SNOW)20,25324,498+4,2453,0556,2351.02%+3,180
CANDEL THERAPEUTICS INC(CADL)405,837405,83701,9894,1800.68%+2,192
TOAST INC(TOST)301,647364,879+63,2327,99710,1511.65%+2,154
SERVICETITAN INC(TTAN)89,856108,545+18,6895,7027,6751.25%+1,973
TAYSHA GENE THERAPIES INC(TSHA)724,873724,87303,2404,9360.80%+1,696
MONDAY COM LTD
SHS
67,86881,982+14,1144,6905,9350.97%+1,244
ACUMEN PHARMACEUTICALS INC(ABOS)3,720,1053,720,10508,7799,9331.62%+1,153
ACRIVON THERAPEUTICS INC2,122,6052,289,271+166,6662,9504,0750.66%+1,124
NU HLDGS LTD(NU)6,537,7697,094,952+557,18393,94894,78915.45%+841
FIGMA INC(FIG)18,28622,165+3,8793874010.07%+14
TARSUS PHARMACEUTICALS INC(TARS)85,00085,00005,9635,3500.87%-613
SAMSARA INC(IOT)560,287515,658-44,62917,75516,7232.73%-1,033
SPYGLASS PHARMA INC(SGP)2,500,0122,500,012064,77555,6509.07%-9,125
KLAVIYO INC(KVYO)3,649,6783,928,146+278,46871,02359,3159.67%-11,708
Page 1 of 1
Sands Capital Alternatives, LLC — 13F Holdings — Q2 2026 | TickerTrail